Search

In conversation with Charles Leclercq (ARxVision)

Julian Jackson (Founder and Director, VisionBridge) spoke to Charles Leclercq (CEO, ARx) about the ARxVision, a wearable device that captures the world around us through audio and artificial intelligence to empower blind and low-vision individuals. You can read the Eye...

A comparison of light sources in retinal imaging

Before starting to talk about the light sources present in retinal imaging, it is necessary to start from the base: the light. Light is an electromagnetic wave whose smallest part is the photon (or quantum of light). A high frequency...

Ophthalmic mentors: In conversation with Professor Harminder Dua

In the first of a series of interviews with key figures in the world of ophthalmology, Eye News speaks to Professor Harminder Dua about the future of clinical academia, his recent College presidency and Dua’s Layer. Professor Harminder Dua is...

The ‘theatre of the mind’: Charles Bonnet Syndrome and Esme’s Umbrella

The founder of Esme’s Umbrella shares her experience with the poorly understood condition Charles Bonnet Syndrome and the creation of the campaign. Many years ago, when I was a young actress, I was in an American play called ‘Butterflies are...

From monofocal to premium: Understanding the expanding landscape of intraocular lenses

For many years cataract surgery was framed almost entirely as a restorative procedure. The goal was straightforward: remove the cloudy lens and replace it with a clear one, restoring distance vision and allowing the patient to function comfortably with reading...

COECSA-RCOphth LINK Partnership: Knowledge sharing from the conference scene

Nick Astbury caught up with President of the Ophthalmology Society of Uganda (OSU), Faith Nakubulwa, and Angela Birungi, Scientific Chair for OSU, to discuss their key learnings taken away from the RCOphth 2026. Nick Astbury (NA): One of the key...

Imaging within clinical research trials

Clinical research is essential to the future of healthcare and the wellbeing of patients, no matter what health condition they face. Many patients who choose to participate in clinical research studies in ophthalmology find optimism in discovering novel medicines to...

Retinoblastoma, CureAll and the role of global clinical, capacity strengthening and research networks

Retinoblastoma (Rb), a rare childhood eye cancer, presents a particularly compelling example of how global health partnerships can operate at the intersection of different medical disciplines, in this case: ophthalmology, oncology and public health. This article places the work of...

The next wave of AI in ophthalmology: From screening to communication

Artificial intelligence (AI) is reshaping ophthalmology, moving from research laboratories into everyday clinical care [1]. With its strong reliance on imaging and pattern recognition, ophthalmology is uniquely positioned to benefit from AI innovations. These developments range from autonomous disease screening...